Showing results (281-290 of 300) with videos related to
Sort By:
Pageof 30
Iscience|April 29, 2024
Pyramidal and parvalbumin neurons modulate the process of electroacupuncture stimulation for stroke rehabilitationXiaorong Tang, Jiahui Shi, Shumin Lin, et al.Helicobacter|April 16, 2025
Efficacy and Safety of Cefuroxime-Tetracycline-Containing Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Penicillin-Allergic Patients: A Multicenter Randomized Controlled TrialHui Wang, Qingzhou Kong, Qiumei Zhang, et al.The Science of the Total Environment|January 26, 2023
Photolysis frequency of nitrophenols derived from ambient measurementsYuwen Peng, Bin Yuan, Suxia Yang, et al.Proceedings of the National Academy of Sciences of the United States of America|November 2, 2022
IER3IP1 is critical for maintaining glucose homeostasis through regulating the endoplasmic reticulum function and survival of β cellsJing Yang, Jinyang Zhen, Wenli Feng, et al.Gynecologic Oncology|October 26, 2024
Molecular classification in fertility-sparing treatment of early-stage endometrial cancer: A potential tool for optimizing patient selectionShiyi Peng, Ying Zheng, Jianhong Liu, et al.Molecular Microbiology|October 29, 2022
Axin1: A novel scaffold protein joins the antiviral network of interferonYujie Guo, Gayan Bamunuarachchi, Kishore Vaddadi, et al.BMC Medical Research Methodology|January 24, 2023
Comparison of State-of-the-Art Neural Network Survival Models with the Pooled Cohort Equations for Cardiovascular Disease Risk PredictionYu Deng, Lei Liu, Hongmei Jiang, et al.Therapeutic Advances in Gastroenterology|March 16, 2026
Discrepancies between patients' and gastroenterologists' perceptions of diagnosis and treatment in ulcerative colitis: a multicenter retrospective studyZhenzhen Fan, Ruixia Li, Xin Liu, et al.International Journal of Nanomedicine|August 12, 2025
Adenovirus Nanoparticles Displaying RBD Induce a Protective Immune Response Against BA.5 in MiceChuncong Mo, Zhongfang Wang, Donglan Liu, et al.Eclinicalmedicine|September 28, 2023
Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trialXiaoqiang Liu, Zhonghan Sun, Zhongfang Wang, et al.Pageof 30